Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition-Reference-Cited by-同舟云学术

Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition

Published:2021-02-01 Issue:8 Volume:77 Page:1157-1168
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Emoto Chie^ORCID,Johnson Trevor N.,Yamada Takaaki,Yamazaki Hiroshi,Fukuda Tsuyoshi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-021-03098-w.pdf

Reference44 articles.

1. Svetitsky S, Leibovici L, Paul M (2009) Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 53(10):4069–4079. https://doi.org/10.1128/AAC.00341-09

2. Zhou L, Gao Y, Cao W, Liu J, Guan H, Zhang H, Shi Y, Lv W, Cheng L (2018) Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections. Infect Drug Resist 11:29–36. https://doi.org/10.2147/IDR.S146961

3. Ramos-Martin V, Johnson A, McEntee L, Farrington N, Padmore K, Cojutti P, Pea F, Neely MN, Hope WW (2017) Pharmacodynamics of teicoplanin against MRSA. J Antimicrob Chemother 72(12):3382–3389. https://doi.org/10.1093/jac/dkx289

4. Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA, Infection Section of European Society of Intensive Care M, Pharmacokinetic/pharmacodynamic, Critically Ill Patient Study Groups of European Society of Clinical M, Infectious D, Infectious Diseases Group of International Association of Therapeutic Drug M, Clinical T, Infections in the ICU, Sepsis Working Group of International Society of Antimicrobial C (2020) Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med 46(6):1127–1153. https://doi.org/10.1007/s00134-020-06050-1

5. Wilson AP (2000) Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet 39(3):167–183. https://doi.org/10.2165/00003088-200039030-00001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models;Expert Opinion on Drug Metabolism & Toxicology;2024-01-25

2. A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM;Journal of Pharmaceutical and Biomedical Analysis;2022-10

3. Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study;Frontiers in Pharmacology;2022-03-08

4. Construction and Interpretation of Prediction Model of Teicoplanin Trough Concentration via Machine Learning;Frontiers in Medicine;2022-03-08

5. Optimal teicoplanin dosing regimen in neonates and children developed by leveraging real-world clinical information;Therapeutic Drug Monitoring;2021-10-08